Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)-Reference-Cited by-同舟云学术

Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review)

Published:2022-04-28 Issue:6 Volume:60 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Sun Guangshun¹,Liu Hanyuan²,Shi Xuesong²,Tan Pengyu³,Tang Weiwei⁴,Chen Xin²,Sun Guoqiang²,Yang Weijun²,Kong Xiangyi⁴,Zheng Zhiying⁵,Cao Hongyong²,Shao Guoqiang⁶

Affiliation:

1. Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210001, P.R. China

2. Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210001, P.R. China

3. Department of Food Science and Engineering, Nanjing Xiaozhuang University, Nanjing, Jiangsu 211166, P.R. China

4. Hepatobiliary/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Transplantation, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 215005, P.R. China

5. Hepatobiliary/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Transplantation, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 215005, P.R. China

6. Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06

2. RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates;Gut;2024-02-21

3. The curious case of Prevotella copri;Gut Microbes;2023-09

4. Therapeutic potential and limitations of curcumin as antimetastatic agent;Biomedicine & Pharmacotherapy;2023-07

5. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses;Cancer Letters;2023-05